Denmark In Vivo Cro Market Size & Outlook, 2023-2030
Denmark in vivo cro market, 2018-2030 (US$M)
Related Markets
Denmark in vivo cro market highlights
- The Denmark in vivo cro market generated a revenue of USD 124.7 million in 2023 and is expected to reach USD 208.0 million by 2030.
- The Denmark market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating modality type in 2023.
- Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.
In vivo cro market data book summary
| Market revenue in 2023 | USD 124.7 million |
| Market revenue in 2030 | USD 208.0 million |
| Growth rate | 7.6% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | IQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group |
Other key industry trends
- In terms of revenue, Denmark accounted for 2.7% of the global in vivo cro market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany in vivo cro market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 328.5 million by 2030.
Small molecule was the largest segment with a revenue share of 63.59% in 2023. Horizon Databook has segmented the Denmark in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
Denmark offers a wide range of well-characterized and validated animal models for preclinical studies. These animal models cover various diseases and conditions, enabling in vivo CROs to conduct targeted and specialized research in collaboration with pharmaceutical companies. The Danish government supports the life sciences industry, including the in vivo CRO sector.
It provides funding, grants, and incentives for R&D activities, promoting innovation and collaboration. For instance, in April 2021, the Danish government launched a new strategy for the life sciences industry, consisting of 38 new initiatives across seven key areas.
These initiatives primarily focus on enhancing R&D conditions, leveraging health data effectively, ensuring the availability of a highly skilled workforce, and creating opportunities for international expansion. These factors would contribute to the growth and competitiveness of Denmark’s in vivo CRO market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vivo CRO Market Scope
In Vivo CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Denmark in vivo cro market size, by modality type, 2018-2030 (US$M)
Denmark In Vivo CRO Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
